Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

Your search for 'crestor' produced 10 results. The area of search was 'All news'

• • Nov 17, 2009
  • CRESTOR® reduced risk of cardiovascular events in women by nearly half in new analysis of JUPITER study  
• • Oct 16, 2009
  • U.S. Food and Drug Administration approves CRESTOR® for use in pediatric patients with heterozygous familial hypercholesterolemia  
• • Sep 1, 2009
  • AstraZeneca encourages all Americans to get their cholesterol checked during National Cholesterol Education Month in September  
• • Aug 31, 2009
  • CRESTOR® reduced risk of cardiovascular events in elderly patients in new analysis of JUPITER  
• • Jun 4, 2009
  • AstraZeneca and Abbott extend relationship to include co-promotion of TRILIPIX® (fenofibric acid)  
• • Jun 4, 2009
  • AstraZeneca and Abbott submit New Drug Application to the FDA for CERTRIAD™, an investigational treatment for mixed dyslipidemia  
• • Mar 30, 2009
  • Patients receiving hemodialysis for treatment of end stage renal disease did not benefit from statin therapy in the AURORA study  
• • Mar 29, 2009
  • CRESTOR® reduced CV risk in patients achieving low LDL and hsCRP targets in new JUPITER analysis  
• • Mar 29, 2009
  • CRESTOR® reduced risk of blood clots in the veins  
• • Feb 19, 2009
  • CRESTOR cuts risk of stroke by nearly half in JUPITER study  

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed